BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3492448)

  • 1. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5.
    Melbye M; Kestens L; Biggar RJ; Schreuder GM; Gigase PL
    Int J Cancer; 1987 Feb; 39(2):182-4. PubMed ID: 3492448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.
    Pollack MS; Safai B; Myskowski PL; Gold JW; Pandey J; Dupont B
    Tissue Antigens; 1983 Jan; 21(1):1-8. PubMed ID: 6601312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and Kaposi's sarcoma in Sardinia.
    Contu L; Cerimele D; Pintus A; Cottoni F; La Nasa G
    Tissue Antigens; 1984 Apr; 23(4):240-5. PubMed ID: 6587615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma.
    Prince HE; Schroff RW; Ayoub G; Han S; Gottlieb MS; Fahey JL
    J Clin Immunol; 1984 May; 4(3):242-5. PubMed ID: 6588054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HLA typing in classical and African Kaposi's disease].
    Lemarchand-Venencie F; Lepace V; Belaich S; Civatte J; Rabian C; Chidiac A; Colombani J; Degos L
    Pathol Biol (Paris); 1986 Jun; 34(6):761-4. PubMed ID: 3531992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma.
    Wahman A; Melnick SL; Rhame FS; Potter JD
    Epidemiol Rev; 1991; 13():178-99. PubMed ID: 1765111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histocompatibility antigens HLA-A, -B, -DR in Greek patients with Kaposi's sarcoma.
    Papasteriades C; Kaloterakis A; Filiotou A; Economidou J; Nicolis G; Trichopoulos D; Stratigos J
    Tissue Antigens; 1984 Nov; 24(5):313-5. PubMed ID: 6335794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA in familial and nonfamilial Mediterranean Kaposi's sarcoma in Greece.
    Kaloterakis A; Papasteriades C; Filiotou A; Economidou J; Hadjiyannis S; Stratigos J
    Tissue Antigens; 1995 Feb; 45(2):117-9. PubMed ID: 7792757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA and Kaposi's sarcoma in solid organ transplantation.
    Brunson ME; Balakrishnan K; Penn I
    Hum Immunol; 1990 Sep; 29(1):56-63. PubMed ID: 2211190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent variation of HLA-antigen-frequencies in HIV-1-infection (1983-1988).
    Kuntz BM; BrĂ¼ster HT
    Tissue Antigens; 1989 Sep; 34(3):164-9. PubMed ID: 2595721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection.
    Scorza Smeraldi R; Fabio G; Lazzarin A; Eisera NB; Moroni M; Zanussi C
    Lancet; 1986 Nov; 2(8517):1187-9. PubMed ID: 2877328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS.
    Mann DL; Murray C; Yarchoan R; Blattner WA; Goedert JJ
    J Acquir Immune Defic Syndr (1988); 1988; 1(1):13-7. PubMed ID: 3216293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and immunogenetic features of primary Kaposi's sarcoma.
    Marinig C; Fiorini G; Boneschi V; Melotti E; Brambilla L
    Cancer; 1985 May; 55(9):1899-901. PubMed ID: 3156665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma in homosexual men. A seroepidemiologic case-control study.
    Marmor M; Friedman-Kien AE; Zolla-Pazner S; Stahl RE; Rubinstein P; Laubenstein L; William DC; Klein RJ; Spigland I
    Ann Intern Med; 1984 Jun; 100(6):809-15. PubMed ID: 6326631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No HLA antigen is significant in classic Kaposi's sarcoma.
    Tzfoni EE; Scherman L; Battat S; Brautbar H
    J Am Acad Dermatol; 1993 Jan; 28(1):118-9. PubMed ID: 8425954
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections.
    Pollack MS; Gold J; Metroka CE; Safai B; Dupont B
    Hum Immunol; 1984 Oct; 11(2):99-103. PubMed ID: 6333416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphadenopathic aggressive Kaposi's sarcoma in a renal transplant recipient with HLA-DR2 and HLA-DR5 antigens.
    Sungur C; Bozdogan O; Sungur A; Oymak O; Yasavul U; Turgan C; Caglar S
    Nephron; 1995; 69(1):122-3. PubMed ID: 7891790
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of HLA-DR5 with mycosis fungoides.
    Safai B; Myskowski PL; Dupont B; Pollack MS
    J Invest Dermatol; 1983 May; 80(5):395-7. PubMed ID: 6601679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigen frequencies in HIV-1-related Kaposi's sarcoma.
    Mann DL; Murray C; O'Donnell M; Blattner WA; Goedert JJ
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S51-5. PubMed ID: 2395088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T-helper (CD4+) cytopenia and HLA-A1, -B8, -C27, -DR3].
    Kuntz BM; Sobieraj B; BrĂ¼ster HT
    Beitr Infusionsther Transfusionsmed; 1994; 32():310-3. PubMed ID: 9480115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.